Rare Cancers Are A Quarter of All Cancers - So Why The Funding Gap? - Video

In this episode of Living With Metastatic Cancer, Dr. Peter Crane interviews Professor Dr. Robin Jones as he shares his career journey from the UK to Seattle and back, the heterogeneity of sarcomas, the importance of the NAB2/STAT6 fusion for accurate SFT diagnosis, emerging site-directed therapies targeting fibroblast activation protein (FAP), anti-angiogenic treatments, and the real-world challenges of research funding and medication access in different healthcare systems. A hopeful and practical conversation for patients, physicians, and researchers dealing with rare cancers.

https://podcasts.apple.com/us/podcast/doctors-making-a-difference/id1753613285?i=1000773213141